Andere Kunden interessierten sich auch für
![Materials Reliability Issues in Microelectronics: Volume 225]( "Materials Reliability Issues in Microelectronics: Volume 225")
Materials Reliability Issues in Microelectronics: Volume 22542,99 €![Boron and Gadolinium Neutron Capture Therapy for Cancer Treatment]( "Boron and Gadolinium Neutron Capture Therapy for Cancer Treatment")
Boron and Gadolinium Neutron Capture Therapy for Cancer Treatment139,99 €![Antimocrobial Photodynamic Inactivation and Antitumor Photodynamic Therapy with Fullerenes]( "Antimocrobial Photodynamic Inactivation and Antitumor Photodynamic Therapy with Fullerenes")
Antimocrobial Photodynamic Inactivation and Antitumor Photodynamic Therapy with Fullerenes40,99 €![Design and Simulation of a Passive-Scattering Nozzle in Proton Therapy]( "Design and Simulation of a Passive-Scattering Nozzle in Proton Therapy")
Design and Simulation of a Passive-Scattering Nozzle in Proton Therapy38,99 €![Photodynamic Therapy]( "Photodynamic Therapy")
Photodynamic Therapy129,00 €![Radon-222 and Radium-226 Activity Concentration Measurement]( "Radon-222 and Radium-226 Activity Concentration Measurement")
Radon-222 and Radium-226 Activity Concentration Measurement47,99 €![Antimocrobial Photodynamic Inactivation and Antitumor Photodynamic Therapy with Fullerenes]( "Antimocrobial Photodynamic Inactivation and Antitumor Photodynamic Therapy with Fullerenes")
Antimocrobial Photodynamic Inactivation and Antitumor Photodynamic Therapy with Fullerenes132,99 €
Radium needles that were once implanted into tumours
as a cancer treatment are now obsolete and constitute
a radioactive waste problem, as their half-life is
1600 years. The increasing application of Ac-225 for
cancer therapy indicates the potential need for its
increased production and availability. The reduction
of radium by photonuclear transmutation by bombarding
Ra-226 with high-energy photons from a medical linac
has been investigated. The irradiated needles would
then be processed to remove the Ac-225, which can
then be used for Targeted Alpha Therapy (TAT) of
cancer.
The research in this monograph investigates the
possibility of producing of Ac-225 in commercial
quantities, which could potentially reduce obsolete
radioactive material and displace the need for
expensive importation of Ac-225 from the USA and
Russia in the years ahead. Scaled up production of
Ac-225 could theoretically be achieved by the use of
a high current cyclotron or linac.
as a cancer treatment are now obsolete and constitute
a radioactive waste problem, as their half-life is
1600 years. The increasing application of Ac-225 for
cancer therapy indicates the potential need for its
increased production and availability. The reduction
of radium by photonuclear transmutation by bombarding
Ra-226 with high-energy photons from a medical linac
has been investigated. The irradiated needles would
then be processed to remove the Ac-225, which can
then be used for Targeted Alpha Therapy (TAT) of
cancer.
The research in this monograph investigates the
possibility of producing of Ac-225 in commercial
quantities, which could potentially reduce obsolete
radioactive material and displace the need for
expensive importation of Ac-225 from the USA and
Russia in the years ahead. Scaled up production of
Ac-225 could theoretically be achieved by the use of
a high current cyclotron or linac.